Moreno et al. specifically studied the relationship between CD38 expression level and isatuximab-mediated modes of action, showing that CDC and ADCP mechanisms are induced only in CD38high MM cells, while ADCC is exerted in MM cells with a broad range of CD38 expression [116]. Here, CD38 is linked to Miyoshi myopathy.